Physician profile
Kim Krmpotic
NPI 1427432939
$78,896.57
in general payments reported to CMS, 2019-2025
29 companies · $7,198 in 2025
The $7,198 reported for 2025 was more than what 99% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12K · 2022: $11K · 2023: $25K · 2024: $23K · 2025: $7,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Consulting Fee: $14K · Food and Beverage: $13K · Travel and Lodging: $8,082.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,900.00 |
| Consulting Fee | $14,118.75 |
| Food and Beverage | $13,115.06 |
| Travel and Lodging | $8,082.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $57,490.15 | 2021-2025 | Watchman Access System, Watchman Flx, General - Therapies |
| Atricure, INC. | $13,815.31 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Novartis Pharmaceuticals Corporation | $1,388.84 | 2021-2025 | |
| Abbott Laboratories | $871.00 | 2022-2025 | Mitraclip, Cardiomems, Aveir |
| Edwards Lifesciences Corporation | $836.00 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Endotronix, INC. | $551.90 | 2022-2025 | Cordella Pulomonary Artery Pressure Sensor |
| Amgen INC. | $426.05 | 2021-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $330.77 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $298.60 | 2021-2025 | Lifevest |
| Medtronic, INC. | $298.44 | 2021-2025 | Micra, Linq II, Endurant Iis |
| Actelion Pharmaceuticals US, INC. | $291.41 | 2021-2025 | Uptravi, Opsumit |
| Pfizer INC. | $276.50 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.15 | 2022-2023 | Jardiance |
| Impulse Dynamics (USA) INC. | $190.97 | 2021-2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $182.28 | 2023-2024 | Onpattro, Amvuttra |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $170.62 | 2022-2024 | |
| Biosense Webster, INC. | $163.67 | 2022-2023 | Carto 3 |
| Astrazeneca Pharmaceuticals Lp | $138.91 | 2023-2024 | Wainua |
| Esperion Therapeutics, INC. | $112.32 | 2025 | Nexletol |
| Philips North America LLC | $112.00 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $105.56 | 2023-2025 | Camzyos, Eliquis |
| Biotronik INC. | $103.60 | 2021-2022 | |
| Heartflow, INC. | $95.02 | 2022 | |
| Abiomed | $94.02 | 2023 | Impella |
| Novo Nordisk INC | $87.91 | 2024-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $86.80 | 2022-2024 | Verquvo |
| Tactile Systems Technology INC | $53.91 | 2023 | Flexitouch Plus, Entre Plus |
| Bayer Healthcare Pharmaceuticals INC. | $41.02 | 2025 | |
| Siemens Medical Solutions USA, INC. | $26.84 | 2025 | Artis Q Floor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Krmpotic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.